Skip to navigation
Skip to main content
Skip to footer
Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United Kingdom
About Us
What We do
Our History
Our Team
Our Advisory Board
Our Purpose
Corporate Responsibility
Careers
Service centres
Healthcare Companies
Pharmaceutical Wholesale
Healthcare Marketing & Sales
Supply Chain Solutions
Clinical & Medical Trials Support
Patient Support Services
Consumer Support Services
Pharmacy Data and Insights
Pharmacy Solutions
Alphega Pharmacy Network
Wholesale Pharmacy Distributors
PenCycle
Added Value Services
Pharmacy Exclusive Products
OptiTote
Re-Hale
Healthcare Professionals
Wholesale
Hospitals
Forte
Homecare
News
Contact Us
Open an account with us
Direct debit mandate
Credit terms
Details of low spend surcharge
Our Licences
Our Supply Chain Arrangements
Press Office
MyAH Portal
Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United Kingdom
About Us
What We do
Our History
Our Team
Our Advisory Board
Our Purpose
Corporate Responsibility
Careers
Service centres
Healthcare Companies
Pharmaceutical Wholesale
Healthcare Marketing & Sales
Supply Chain Solutions
Clinical & Medical Trials Support
Patient Support Services
Consumer Support Services
Pharmacy Data and Insights
Pharmacy Solutions
Alphega Pharmacy Network
Wholesale Pharmacy Distributors
PenCycle
Added Value Services
Pharmacy Exclusive Products
OptiTote
Re-Hale
Healthcare Professionals
Wholesale
Hospitals
Forte
Homecare
News
Contact Us
Open an account with us
Direct debit mandate
Credit terms
Details of low spend surcharge
Our Licences
Our Supply Chain Arrangements
Press Office
MyAH Portal
Section 172 (1) Statement (OTC DIRECT)
Section 172(1) Statement - OTC Direct_ABC.pdf
×
Search
Search Keyword
Search Results
Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United Kingdom